EDITOR'S CHOICE AWARD 2024

BioSpectrum Asia Excellence Awards 2024 - Editor's Choice

The world has realised that the next generation medical products will need Asian inputs to become successful. So, they are flocking to set up their research facilities, do a large part of their drug discovery work and conduct clinical trials in a big way to speed up the drug development process.

To appreciate the Asian companies for their commendable performance and achievements during Calendar Year (CY) 2023, and noting that Asia is the new hub for potential growth and innovation, BioSpectrum Asia is setting the tone for an exciting opportunity in the form of BioSpectrum Asia Excellence Awards 2024.

These awards were an extension to observe and highlight the winners in the long battle to tackle the world's emerging health problems and find solutions. Through these awards, BioSpectrum Asia is playing the role of picking tomorrow's winners, nudging today's entrepreneurs to achieve greater glory and honouring yesterday's key players who laid the foundation for success

The nominations were received for the following categories under the Editor's Choice Special Awards 2024-

• Top company for BioprocessingNominations are closed!
• Top company in Manufacturing Technology and Equipment
• Top company for API Development
• Top company for Analysis, Testing, and Quality Control
• Top company in Packaging & Drug Delivery Services
• Top company in Supply Chain, Logistics, and Distribution
• Top company in Clinical Research-Based Development
• Top Innovation & Collaborations in ADC Drug Development
• Excellence in MedTech Innovations
• Innovative Space Solutions Awards
• Innovative Biotech Solutions AwardNominations are closed!
• Sustainability in Lab Water Solutions Award

Nomination criteria for each-

• Achievements in CY 2023
• Challenges faced & solved in CY 2023
• Novelty/ Uniqueness added in CY 2023
• Competitive advantage
• Other efficiencies in CY 2023